Augmedix raises $16M Series A for its Google Glass powered health records management solution
Darrell Etherington / TechCrunch :
Context & Ripple Effects
Augmedix's $16M Series A is a bet that Google Glass can find a market after the device's consumer failure — privacy backlash and ridicule kept it out of homes, but the enterprise repositioning left room for vertical applications. This round lands weeks before Meta's $23M Series A for augmented reality glasses, showing investors in January 2015 were funding head-worn computing despite Glass's consumer collapse.
The arc validates quickly: by 2016 Augmedix had raised again with its $17M follow-on to 'rehumanize' doctor/patient relations, and by late 2016 the company had cleared $36M total while putting Glass-based remote scribing in front of hundreds of US doctors.
First-order effects
- Augmedix gets capital to scale its medical scribing service, where doctors wear Glass during patient visits and offsite scribes handle documentation — directly attacking the records burden that consumes physician time.
- Google gains an early proof point for Glass as a workplace tool, reinforcing its pivot from failed consumer gadget toward the enterprise line.
Second-order effects
- Competing ambient-documentation and AR startups gain a fundraising benchmark: Meta's Series A weeks later shows head-worn computing attracting parallel bets rather than ceding the category to Glass alone.
- Health systems evaluating electronic-records workflows get a new vendor option, pressuring incumbent EHR-centric process design around how clinician time is allocated.
Third-order effects
- If Glass survives anywhere, it is as infrastructure inside regulated verticals like medicine — a template for consumer-failed hardware being rescued by professional use cases where utility outweighs social awkwardness.
- Clinical documentation drifts from a task doctors perform at keyboards toward delegated capture — human scribes first, automation layered on later — restructuring how healthcare pays for recordkeeping.
The trend: Consumer-rejected wearable hardware is finding a second life in enterprise verticals like medicine, with Augmedix's funding run as an early data point in Glass's enterprise pivot.